Integration of Antiretroviral Therapy with Tuberculosis Treatment
Author(s) -
Salim S. Abdool Karim,
Kogieleum Naidoo,
Anneke Grobler,
Nesri Padayatchi,
Cheryl Baxter,
Andy Gray,
Tanuja N. Gengiah,
Santhanalakshmi Gengiah,
Anushka Naidoo,
Niraksha Jithoo,
Gonasagrie Nair,
Wafaa ElSadr,
Gerald Friedland,
Quarraisha Abdool Karim
Publication year - 2011
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1014181
Subject(s) - medicine , tuberculosis , incidence (geometry) , sputum , antiretroviral therapy , mortality rate , confidence interval , viral load , surgery , human immunodeficiency virus (hiv) , immunology , pathology , physics , optics
We previously reported that integrating antiretroviral therapy (ART) with tuberculosis treatment reduces mortality. However, the timing for the initiation of ART during tuberculosis treatment remains unresolved.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom